Although NIH guidelines recommend daily inhaled corticosteroids as the mainstay of treatment for mild persistent asthma, patient adherence is variable. In this double-blind trial, researchers ...

According to national guidelines, mild persistent asthma is defined by a need for β-agonist treatment more than 2 days per week (but less than daily), asthma-related nighttime awakenings more ...